Chronic News and Research

RSS

Geisinger, InVivo to conduct injectable biocompatible hydrogel preclinical study for PNI

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and Geisinger Health System today announced a research collaboration to conduct a preclinical study using InVivo's injectable biocompatible hydrogel for the treatment of chronic pain caused by peripheral nerve compression.

17 Jan 2012

UBC study: 1 in 10 Canadians cannot afford prescription drugs

One in 10 Canadians have problems affording medications they have been prescribed, and one in four people without drug insurance cannot afford to have their prescriptions filled, according to a study in CMAJ.

17 Jan 2012

Risk factors associated with increased likelihood of long-term disability in older people

Yale School of Medicine researchers have found that the likelihood of becoming disabled with age increases with the following factors: having a chronic condition or cognitive impairment; low physical activity; slower gross motor coordination; having poor lower-extremity function; and being hospitalized. Women are also more likely than men to become disabled in their later years.

17 Jan 2012

Newtricious secures backing of a consortium of investors

Life Sciences company Newtricious has secured the backing of a consortium of investors who will help it to continue to develop its first products focusing on the maintenance of health in people at risk for chronic diseases such as macular degeneration and cardiovascular illnesses.

17 Jan 2012

Angioplasty improves quality of life in MS patients

Although using angioplasty to treat multiple sclerosis (MS) is highly controversial, sufferers often insist it helps - in some cases dramatically, such as allowing them to walk without a cane. Patients with less severe MS also reported additional quality of life improvements, such as being able to talk more clearly, after having treatment to open blocked blood vessels in the chest and neck, according to research being presented at the 24th annual International Symposium on Endovascular Therapy.

17 Jan 2012

New way to block HCV infection in the liver

Researchers at the University of British Columbia have found a new way to block infection from the hepatitis C virus (HCV) in the liver that could lead to new therapies for those affected by this and other infectious diseases.

17 Jan 2012

Hormone that burns energy discovered

Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.

16 Jan 2012

Annual stress survey reveals 1 in 5 Americans under pressure

Each year the American Psychological Association releases its “Stress in America” survey. The last was released yesterday and it showed that too many Americans are stressed.

15 Jan 2012

Viewpoints: GOP moving away from compassionate conservatism; Competing strategies for fighting obesity

Romney asserts that President Obama wants to "fundamentally transform America," turning the country "into a European-style entitlement society." In fact, (Mitt) Romney and his Republican presidential rivals have a far more radical transformation in mind. They envision a dramatically shrunken federal government and a dangerously unraveled social safety net.

13 Jan 2012

MYTHOS clinical trial demonstrates superiority of RenalGuard in reducing CIN

PLC Systems Inc., a company focused on innovative medical device technologies, today announced that final results from the MYTHOS investigator-sponsored clinical trial of RenalGuard in Italy have been published in the January 2012 issue of JACC – Cardiovascular Interventions, a peer-reviewed journal of the American College of Cardiology.

13 Jan 2012

Chamber president calls for entitlement reform

Tom Donohue, the president and CEO of the U.S. Chamber of Commerce, says Medicare, Medicaid and Social Security costs must be tamed.

13 Jan 2012

Researchers discover previously unknown effect of opioids

A team of researchers at the MedUni Vienna's Department of Neurophysiology has discovered a previously unknown effect of opioids: the study, which has now been published in the highly respected magazine "Science" and was led by Ruth Drdla-Schutting and Jürgen Sandkühler, shows that opioids not only temporarily relieve pain, but at the right dose can also erase memory traces of pain in the spinal cord and therefore eliminate a key cause of chronic pain.

13 Jan 2012

Complex PCI: Left Main and CTO Summit to be held Feb. 23-25, 2012

The Complex PCI: Left Main and CTO Summit is a three-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions.

13 Jan 2012

WHO to convene meeting on yaws eradication efforts based on study of oral treatment

"Findings that a one-time oral treatment to cure yaws, a neglected tropical disease, is as effective as the currently recommended penicillin injection have prompted the World Health Organization (WHO) to convene a meeting on how the disease may be wiped out," IRIN reports.

13 Jan 2012

New lab test quickly identifies bacterium responsible for staph infections

Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus.

13 Jan 2012

TPRF continues to sponsor eye clinics in rural India

The Prem Rawat Foundation (TPRF) continues to sponsor eye clinics in rural India, most recently by providing US$30,000 to cover the cost of services to nearly 7,000 residents in the states of Jharkhand, Bihar, Uttarakhand and Uttar Pradesh.

13 Jan 2012

SAA protein plays a key role in chronic inflammation and lung damage in COPD

Sufferers of smoking related lung diseases could have their debilitating symptoms reduced following the discovery of a potential new treatment.

13 Jan 2012

Mass media information may turn out to be of help for health

It is time to leave apart the belief that mass media are always a source of bad habits. Television, newspaper and the Internet, when used to get information, may turn out to be of help for health.

13 Jan 2012

Kedem commences development of Gleevec to treat CML in children and adults

Kedem Pharmaceuticals Inc., a specialty pharmaceutical company with focus on sublingual drug delivery system is pleased to announce that has initiated the development of Gleevec.

12 Jan 2012

Low-glycemic-load diet reduces C-reactive protein associated with chronic disease

Among overweight and obese adults, a diet rich in slowly digested carbohydrates, such as whole grains, legumes and other high-fiber foods, significantly reduces markers of inflammation associated with chronic disease, according to a new study by Fred Hutchinson Cancer Research Center.

12 Jan 2012